Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-10 · accession 0001133416-25-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-11-12 | 2025-11-10 | GALT | CALLICUTT JACK W | CFO | M - OptEx | $1.46 | +5,291 | 9,694 | +120% | +$7,717 |
| DMT | 2025-11-12 | 2025-11-10 | GALT | CALLICUTT JACK W | CFO | S - Sale+OE | $6.03 | -5,291 | 7,614 | -41% | -$31.9K |
| DMT | 2025-11-12 | 2025-11-10 | GALT | CALLICUTT JACK W | CFO | M - OptEx | $0.00 | -5,291 | 37.7K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2025-11-10 | M | A | 1,736 | $1.23 | 9,350 | D | — | — | |
| 2 | Common | Common stock | 2025-11-10 | S | D | 1,736 | $6.03 | 7,614 | D | — | — | (F5) The shares were sold in multiple transactions at prices ranging from $6.00 to $6.14. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 3 | Common | Common stock | 2025-11-10 | S | D | 1,880 | $6.02 | 7,614 | D | — | — | (F5) The shares were sold in multiple transactions at prices ranging from $6.00 to $6.14. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 4 | Common | Common stock | 2025-11-10 | M | A | 1,675 | $1.11 | 9,289 | D | — | — | |
| 5 | Common | Common stock | 2025-11-10 | M | A | 1,880 | $1.98 | 9,694 | D | — | — | |
| 6 | Common | Common stock | 2025-11-10 | S | D | 1,675 | $6.03 | 7,614 | D | — | — | (F5) The shares were sold in multiple transactions at prices ranging from $6.00 to $6.14. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. |
| 7 | Derivative | Stock option (right to buy) | 2025-11-10 | M | D | 1,736 | $0.00 | 51,073 | D | $1.23 · 2025-06-30 to 2035-01-22 | 1,736 Common stock | (F4) The options vests as follows: 25% on June 30, 2025, with 25% scheduled to vest on each of December 31, 2025, June 30, 2026, on December 31, 2026. |
| 8 | Derivative | Stock option (right to buy) | 2025-11-10 | M | D | 1,675 | $0.00 | 37,891 | D | $1.11 · 2023-06-30 to 2034-01-26 | 1,675 Common stock | (F3) The options vested as follows: 25% on each of June 30, 2023, December 31, 2023, June 30, 2024, and December 31, 2024. |
| 9 | Derivative | Stock option (right to buy) | 2025-11-10 | M | D | 1,880 | $0.00 | 37,706 | D | $1.98 · 0022-06-30 to 2032-01-24 | 1,880 Common stock | (F2) The options vested as follows: 25% on each of June 30, 2022, December 31, 2022, June 30, 2023, and December 31, 2023. |